Application of Pharmacoeconomics to Formulary Decision Making in Managed Care Organizations

Dong-Churl Suh, PhD, MBA;Ijeoma R. N. Okpara, PharmD;Wendy B. Agnese, PharmD;Michael Toscani, PharmD;

Publication

Article

February 1, 2002

The American Journal of Managed Care

February 2002

Volume8

Issue 2

Application of Pharmacoeconomics to Formulary Decision Making in Managed Care Organizations

Author(s):

Dong-Churl Suh, PhD, MBA,Ijeoma R. N. Okpara, PharmD

Download PDF: Application of Pharmacoeconomics to Formulary Decision Making in Managed Care Organizations

Articles in this issue

Evaluation of Agreements Between Managed Care Organizations and Providers of Community-Based Mental Illness and Addiction Disorder Treatments

"Trial" Prescriptions to Reduce Drug Wastage: Results From Canadian Programs and a Community Demonstration Project

Application of Pharmacoeconomics to Formulary Decision Making in Managed Care Organizations

Comparison of Two Systems for Clinical Practice Profiling in Diabetic Care: Medical Records Versus Claims and Administrative Data

A Comparison of Ambulatory Services for Patients with Managed Care and Fee-for-Service Insurance

A New Method for Determining Patient Payments for Outpatient Drugs

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

September 6th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 6th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 6th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 6th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 6th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 6th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Mario Enrico Canonico, MD, PhD Judith Hsia, MD Shih-Ting Chiu, PhD Pu-Kai Tseng James O. Mudd, MD Joshua D. Remick, MD Bansi Patel, MS Ya-Hsiu Chuang, PhD Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Marc P. Bonaca, MD, MPH

Related Content

September 6th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 6th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 6th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 6th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 6th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 6th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Application of Pharmacoeconomics to Formulary Decision Making in Managed Care Organizations

Newsletter